117 related articles for article (PubMed ID: 6683629)
1. An EORTC phase II study of vindesine in advanced prostate cancer.
Jones WG; Fosså SD; Denis L; Coninx P; Glashan RW; Akdas A; De Pauw M
Eur J Cancer Clin Oncol; 1983 May; 19(5):583-8. PubMed ID: 6683629
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of vindesine in advanced head and neck cancer.
Cheng E; Young CW; Wittes RE
Cancer Treat Rep; 1980; 64(10-11):1141-2. PubMed ID: 7459901
[TBL] [Abstract][Full Text] [Related]
3. A multicentre phase II trial of vindesine in malignant melanoma.
Carmichael J; Atkinson RJ; Calman KC; Mackie RM; Naysmith AM; Smyth JF
Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1293-5. PubMed ID: 6891927
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin and vindesine combination chemotherapy in advanced malignant melanoma: an EORTC phase II study.
Mulder JH; Dodion P; Cavalli F; Czarnetzki B; Clavel M; Thomas D; Suciu S; Rozencweig M
Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1297-301. PubMed ID: 6891928
[TBL] [Abstract][Full Text] [Related]
5. Vindesine in the treatment of breast cancer.
Smith IE; Powles TJ
Cancer Chemother Pharmacol; 1979; 2(4):261-2. PubMed ID: 455585
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of vindesine in advanced neoplastic disease.
Stambaugh JE
Cancer Treat Rev; 1980 Sep; 7 Suppl 1():75-9. PubMed ID: 7438126
[No Abstract] [Full Text] [Related]
7. Phase II study of vindesine in patients with advanced breast cancer.
Walker BK; Raich PC; Fontana J; Subramanian VP; Rogers JS; Knost JA; Denning B
Cancer Treat Rep; 1982 Sep; 66(9):1729-32. PubMed ID: 6288237
[TBL] [Abstract][Full Text] [Related]
8. Vindesine in patients with metastatic malignant melanoma: a Southwest Oncology Group study.
Quagliana JM; Stephens RL; Baker LH; Costanzi JJ
J Clin Oncol; 1984 Apr; 2(4):316-9. PubMed ID: 6707719
[TBL] [Abstract][Full Text] [Related]
9. A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung.
Fuks JZ; Aisner J; Carney DN; Van Echo DA; Ostrow SS; Ihde DC; Wiernik PH
Am J Clin Oncol; 1982 Feb; 5(1):49-52. PubMed ID: 6282108
[TBL] [Abstract][Full Text] [Related]
10. Vindesine chemotherapy in lung cancer.
Natale RB; Gralla RJ; Wittes RE; Golbey RB; Young CW
Cancer Treat Rev; 1980 Sep; 7 Suppl 1():59-63. PubMed ID: 7438123
[No Abstract] [Full Text] [Related]
11. Vindesine in head and neck cancer. A Southwest Oncology Group Phase II pilot study.
Haas CD; Fabian CJ; Stephens RL; Kish J
Invest New Drugs; 1983; 1(4):339-40. PubMed ID: 6678881
[TBL] [Abstract][Full Text] [Related]
12. Vindesine in advanced renal cancer. A study of the EORTC Genito-urinary Tract Cancer Cooperative Group.
Fosså SD; Denis L; van Oosterom AT; de Pauw M; Stoter G
Eur J Cancer Clin Oncol; 1983 Apr; 19(4):473-5. PubMed ID: 6305668
[TBL] [Abstract][Full Text] [Related]
13. Vindesine: a phase II study in childhood malignancies-a report for cancer and leukemia group B.
Ettinger LJ; Brecher M; Coleman M; Smithson WA; Patterson R; Russell EC; Necheles T; Jones B; Ohnuma T
Med Pediatr Oncol; 1982; 10(1):35-43. PubMed ID: 7038420
[TBL] [Abstract][Full Text] [Related]
14. Vindesine in the treatment of small cell anaplastic bronchogenic carcinoma.
Osterlind K; Dombernowsky P; Sørensen PG; Hansen HH
Cancer Treat Rep; 1981; 65(3-4):245-8. PubMed ID: 6263469
[TBL] [Abstract][Full Text] [Related]
15. [Phase II study of vindesine in patients with carcinoma of the lung and metastatic pulmonary tumor].
Shibuya M; Saijo N; Shimizu E; Eguchi K; Shinkai T; Tominaga K; Shimabukuro Z
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1808-13. PubMed ID: 6307176
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of vindesine in patients with metastatic breast cancer.
Cobleigh MA; Williams SD; Einhorn LH
Cancer Treat Rep; 1981; 65(7-8):659-63. PubMed ID: 7248983
[TBL] [Abstract][Full Text] [Related]
17. EORTC Phase II chemotherapy studies in prostate cancer.
Jones WG
Prog Clin Biol Res; 1985; 185A():435-45. PubMed ID: 3929268
[No Abstract] [Full Text] [Related]
18. Vindesine in advanced breast cancer, lymphoma and melanoma. A Colorado Clinical Oncology Group study.
DiBella NJ; Berris R; Garfield D; Fink K; Speer J; Sakamoto A
Invest New Drugs; 1984; 2(3):323-8. PubMed ID: 6511238
[TBL] [Abstract][Full Text] [Related]
19. Vindesine for metastatic malignant melanoma. A phase II trial.
Nelimark RA; Peterson BA; Vosika GJ; Conroy JA
Am J Clin Oncol; 1983 Oct; 6(5):561-4. PubMed ID: 6613921
[TBL] [Abstract][Full Text] [Related]
20. [Phase II study of vindesine in patients with primary bronchogenic carcinoma by Cooperative Study Group].
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1838-43. PubMed ID: 6882007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
